AJP - GI Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Gastrointest Liver Physiol 295: G1139-G1149, 2008. First published October 16, 2008; doi:10.1152/ajpgi.90516.2008
0193-1857/08 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
295/6/G1139    most recent
90516.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chichlowski, M.
Right arrow Articles by Hale, L. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chichlowski, M.
Right arrow Articles by Hale, L. P.

REVIEW

Bacterial-mucosal interactions in inflammatory bowel disease—an alliance gone bad

Maciej Chichlowski and Laura P. Hale

Department of Pathology, Duke University Medical Center, Durham, North Carolina

Submitted 26 August 2008 ; accepted in final form 14 October 2008

ABSTRACT

The complex interaction of genetic, microbial, and environmental factors may result in continuous activation of the mucosal immune system leading to inflammatory bowel disease (IBD). Most present treatments for IBD involve altering or suppressing the aberrant immune response; however, the role of the intestinal microbiota in the pathophysiology of IBD is becoming more evident. The epithelial layer is essential for the proper functioning of the gastrointestinal tract, and its increased permeability to the luminal antigens may lead to the inflammatory processes and mucosal damage observed in IBD. Factors affecting the efficacy of the epithelial barrier include presence of pathogenic bacteria (e.g., Helicobacter spp.), presence of probiotic bacteria, availability of selected nutrients, and others. Defective function of the mucosal barrier might facilitate the contact of bacterial antigens and adjuvants with innate and adaptive immune cells to generate prolonged inflammatory responses. This review will briefly describe the complex structure of the epithelial barrier in the context of bacterial-mucosal interactions observed in human IBD and mouse models of colitis.

enteric bacteria; permeability; inflammation



Address for reprint requests and other correspondence: L. Hale, DUMC 3712, Duke Univ. Medical Ctr., Durham, NC 27710 (e-mail: laura.hale{at}duke.edu)




This article has been cited by other articles:


Home page
NeoReviewsHome page
R. Sharma, C. Young, M. Mshvildadze, and J. Neu
Intestinal Microbiota: Does It Play a Role in Diseases of the Neonate?
NeoReviews, April 1, 2009; 10(4): e166 - e179.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.